featured
Continuous vs Intermittent Extended Adjuvant Letrozole for Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
Ann. Oncol 2021 Aug 10;[EPub Ahead of Print], G Jerusalem, S Farah, A Courtois, J Chirgwin, S Aebi, P Karlsson, P Neven, E Hitre, MP Graas, E Simoncini, E Abdi, C Kamby, A Thompson, S Loibl, J Gavilá, K Kuroi, C Marth, B Müller, S O'Reilly, A Gombos, T Ruhstaller, HJ Burstein, M Rabaglio, B Ruepp, K Ribi, G Viale, RD Gelber, AS Coates, S Loi, A Goldhirsch, MM Regan, M ColleoniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.